Table 1. Disease characteristics. Active-smokers vs non-smokers
| Disease characteristics | All patients | Active smokers | Non-smokers | p |
|---|---|---|---|---|
| (N=204) | (N=60) | smokers (N=111) | ||
| Female (%) | 82.4% | 65% | 94.6% | 0.000 |
| Age at diagnosis | 53.6±15.9 | 46.89±13.4 | 57.44±16.3 | 0.000 |
| Disease duration (months) | 9.6±6 | 8.36±4.6 | 10.24±6 | 0.023 |
| RF+ | 80.9% | 91.7% | 76.6% | 0.021 |
| RF titre (UI/L) | 271.8±486 | 409.25±722.9 | 192.51±313.8 | 0.030 |
| Anti-CCP+ | 76.5% | 81.7% | 73.9% | NS |
| Anti-CCP (UI/L) | 611.8±635.3 | 646.61±627.7 | 587.40±633.6 | NS |
| SE+ | 65.7% | 84.6% | 58% | 0.001 |
| VAS Pain (0-100) | 44.96±26 | 47.46±25.7 | 44.72±25.9 | NS |
| Pax Global Assessment | 56.77±16.4 | 57.17±19.1 | 57.13±14.6 | NS |
| DAS28 (VSG) | 5.42±1.1 | 5.37±1.2 | 5.52±0.9 | NS |
| mHAQ | 0.837±0.58 | 0.862±0.58 | 0.856±0.6 | NS |
| ESR | 39.84±26.4 | 36.24±22.5 | 39.12±24.2 | NS |
| CRP | 2.74±3.1 | 2.51±2.5 | 2.87±3.4 | NS |
| Larsen Score | 1.73±6.4 | 1.83±6.2 | 0.98±2.5 | NS |
p-values >0.05.